Silver Book

Silver Book Fact

Impact of a healthy lifestyle on age-related macular degeneration (AMD)

A study exploring the impact of a healthy lifestyle on age-related macular degeneration (AMD) found that women whose diets were the healthiest (scored on the 2005 Healthy Eating Index) had 46% lower odds of developing early AMD than those whose diets were the least healthy.  It also found that women with the most physical activity had 54% lower odds for early AMD compared to those with the least amount of physical activity.

Mares, Julie A., Rick P. Voland, Sherie A. Sondel, Amy E. Millen, Tara LaRowe, Suzen M. Moeller, Mike L. Klein, Barbara A. Blodi, Richard J. Chappel, Lesley Tinker, Cheryl Ritenbaugh, Karen M Gehrs, Gloria E. Sarto, Elizabeth Johnson, Max Snodderly. Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration. Arch Ophthalmol. 2011; 129(4): 322-326. http://archopht.jamanetwork.com/article.aspx?articleid=427181

Reference

Title
Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration
Publication
Arch Ophthalmol
Publication Date
2011
Authors
Mares, Julie A., Rick P. Voland, Sherie A. Sondel, Amy E. Millen, Tara LaRowe, Suzen M. Moeller, Mike L. Klein, Barbara A. Blodi, Richard J. Chappel, Lesley Tinker, Cheryl Ritenbaugh, Karen M Gehrs, Gloria E. Sarto, Elizabeth Johnson, Max Snodderly
Volume & Issue
Volume 129, Issue 4
Pages
322-326
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Intensive glucose control (3 or more daily insulin injections or continuous subcutaneous insulin infusion) reduced the mean risk of retinopathy by 76% in type 1 diabetes patients who had not…  
  • Macugen to treat wet age-related macular degeneration (AMD)
    A new FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)– pegaptanib sodium (Macugen)– reduced vision loss in 70% of clinical trial patients.  
  • Supplementation with lutein increases macular pigment optical density by 27%; which is correlated with benefits in visual function.  
  • The ACCORD Eye Study found that intensive glycemia control–compared with standard blood sugar control–in high risk type 2 diabetics, decreased progression of diabetic retinopathy by around 1/3 over 4 years–from…  
  • Treatment costs for a patient with early-stage glaucoma are about $2,000 less than those of a patient diagnosed with a later stage of the disease.